These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36316125)

  • 1. Author Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo BF
    Neurology; 2022 Nov; 99(18):819. PubMed ID: 36316125
    [No Abstract]   [Full Text] [Related]  

  • 2. Reader Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Vargas WS
    Neurology; 2022 Nov; 99(18):818-819. PubMed ID: 36316124
    [No Abstract]   [Full Text] [Related]  

  • 3. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
    Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of multiple sclerosis in Slovakia - from 2015 to 2020.
    Babela R; Dugas J
    BMC Health Serv Res; 2022 Dec; 22(1):1467. PubMed ID: 36461018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The national economic burden of rare disease in the United States in 2019.
    Yang G; Cintina I; Pariser A; Oehrlein E; Sullivan J; Kennedy A
    Orphanet J Rare Dis; 2022 Apr; 17(1):163. PubMed ID: 35414039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective.
    Davis LL; Schein J; Cloutier M; Gagnon-Sanschagrin P; Maitland J; Urganus A; Guerin A; Lefebvre P; Houle CR
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35485933
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic burden of periodontitis in the United States and Europe: An updated estimation.
    Botelho J; Machado V; Leira Y; Proença L; Chambrone L; Mendes JJ
    J Periodontol; 2022 Mar; 93(3):373-379. PubMed ID: 34053082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Burden of Schizophrenia in the United States.
    Kadakia A; Catillon M; Fan Q; Williams GR; Marden JR; Anderson A; Kirson N; Dembek C
    J Clin Psychiatry; 2022 Oct; 83(6):. PubMed ID: 36244006
    [No Abstract]   [Full Text] [Related]  

  • 10. ECONOMIC BURDEN OF MULTIPLE SCLEROSIS IN GEORGIA.
    Gugutsidze D; Gigineishvili D; Kiziria M; Vashadze T; Tsiskaridze A; Shakarishvili R
    Georgian Med News; 2022 Jan; (322):167-170. PubMed ID: 35134781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.
    Paz-Zulueta M; Parás-Bravo P; Cantarero-Prieto D; Blázquez-Fernández C; Oterino-Durán A
    Mult Scler Relat Disord; 2020 Aug; 43():102162. PubMed ID: 32442885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data.
    Le HH; Ken-Opurum J; LaPrade A; Maculaitis MC; Sheehan JJ
    Mult Scler Relat Disord; 2022 Sep; 65():103971. PubMed ID: 35843012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
    Adelman G; Rane SG; Villa KF
    J Med Econ; 2013; 16(5):639-47. PubMed ID: 23425293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Economic Burden of Cancer in Canada from a Societal Perspective.
    Garaszczuk R; Yong JHE; Sun Z; de Oliveira C
    Curr Oncol; 2022 Apr; 29(4):2735-2748. PubMed ID: 35448197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with multiple sclerosis: a burden and cost of illness study.
    Battaglia MA; Bezzini D; Cecchini I; Cordioli C; Fiorentino F; Manacorda T; Nica M; Ponzio M; Ritrovato D; Vassallo C; Patti F
    J Neurol; 2022 Sep; 269(9):5127-5135. PubMed ID: 35604465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States.
    DeFlorio-Barker S; Shrestha A; Dorevitch S
    Emerg Infect Dis; 2021 Aug; 27(8):2241-2242. PubMed ID: 34287139
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P
    J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: Frequency, cost, and economic burden in the United States.
    Chen AY; Chonghasawat AO; Leadholm KL
    J Clin Neurosci; 2017 Nov; 45():180-186. PubMed ID: 28676312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.